<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Parvo B19 (<z:e sem="disease" ids="C0085273" disease_type="Disease or Syndrome" abbrv="">Fifth disease</z:e>) is an erythrotropic virus which attaches through the 'P' globoside receptor on the surface of human red blood cells and precursors </plain></SENT>
<SENT sid="1" pm="."><plain>This typically benign <z:mp ids='MP_0001799'>viral</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> can cause a transient <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> in patients with underlying red cell disorders </plain></SENT>
<SENT sid="2" pm="."><plain>In this case, a two-year-old child presents with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> without evidence of underlying disease </plain></SENT>
<SENT sid="3" pm="."><plain>Erythroid regeneration is monitored through the use of the immature reticulocyte fraction (IRF) and is demonstrated by the presence of high and medium fluorescence reticulocytes in the peripheral blood three to five days prior to the peak in absolute reticulocytes </plain></SENT>
</text></document>